Sabine Fürst‐Recktenwald

418 total citations
12 papers, 278 citations indexed

About

Sabine Fürst‐Recktenwald is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sabine Fürst‐Recktenwald has authored 12 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Sabine Fürst‐Recktenwald's work include Sarcoma Diagnosis and Treatment (4 papers), Surgical site infection prevention (2 papers) and Pharmaceutical studies and practices (2 papers). Sabine Fürst‐Recktenwald is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Surgical site infection prevention (2 papers) and Pharmaceutical studies and practices (2 papers). Sabine Fürst‐Recktenwald collaborates with scholars based in Switzerland, United Kingdom and France. Sabine Fürst‐Recktenwald's co-authors include Kieran McHugh, Daniel Orbach, Norbert Stefan, Paul Jordan, Silke Hornemann, Hans‐Ulrich Häring, S. Kahl, Jonghee Hwang, Andreas Pfeiffer and Milind Ronghe and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Sabine Fürst‐Recktenwald

12 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabine Fürst‐Recktenwald Switzerland 7 75 73 70 60 51 12 278
Zijian Tian China 10 49 0.7× 75 1.0× 81 1.2× 44 0.7× 10 0.2× 33 244
Halil Gürhan Karabulut Türkiye 11 28 0.4× 130 1.8× 43 0.6× 20 0.3× 24 0.5× 42 369
Pernille M. Hansen Denmark 12 152 2.0× 75 1.0× 20 0.3× 21 0.3× 21 0.4× 19 402
Saba Kiremitçi Türkiye 10 54 0.7× 76 1.0× 47 0.7× 52 0.9× 5 0.1× 42 266
Sevilay Sezer Türkiye 12 61 0.8× 46 0.6× 28 0.4× 166 2.8× 12 0.2× 14 352
Nicholas Fung Hong Kong 8 11 0.1× 35 0.5× 51 0.7× 39 0.7× 67 1.3× 16 264
Dandan Zhu China 8 9 0.1× 70 1.0× 67 1.0× 25 0.4× 66 1.3× 22 241
Lárus Jónasson Iceland 9 76 1.0× 42 0.6× 97 1.4× 6 0.1× 27 0.5× 19 343
Takahisa Kobayashi Japan 10 40 0.5× 166 2.3× 54 0.8× 18 0.3× 4 0.1× 23 380
Meredith Kato United States 8 282 3.8× 40 0.5× 27 0.4× 47 0.8× 20 0.4× 17 415

Countries citing papers authored by Sabine Fürst‐Recktenwald

Since Specialization
Citations

This map shows the geographic impact of Sabine Fürst‐Recktenwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Fürst‐Recktenwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Fürst‐Recktenwald more than expected).

Fields of papers citing papers by Sabine Fürst‐Recktenwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Fürst‐Recktenwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Fürst‐Recktenwald. The network helps show where Sabine Fürst‐Recktenwald may publish in the future.

Co-authorship network of co-authors of Sabine Fürst‐Recktenwald

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Fürst‐Recktenwald. A scholar is included among the top collaborators of Sabine Fürst‐Recktenwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Fürst‐Recktenwald. Sabine Fürst‐Recktenwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Choi, YounJeong, Nathalie Barbier, Sabine Fürst‐Recktenwald, et al.. (2022). Analysis and reporting of pediatric growth and development assessment from clinical trials: overview and challenges. Journal of Biopharmaceutical Statistics. 33(6). 786–799. 3 indexed citations
3.
Cameron, Alison, Markus C. Elze, Michela Casanova, et al.. (2021). The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma. International Journal of Radiation Oncology*Biology*Physics. 111(4). 968–978. 17 indexed citations
4.
Müller, Hermann L., Johannes H. M. Merks, Birgit Geoerger, et al.. (2018). Integrated analysis of long‐term growth and bone development in pediatric and adolescent patients receiving bevacizumab. Pediatric Blood & Cancer. 66(2). e27487–e27487. 5 indexed citations
5.
Chakravarthy, Usha, Clare Bailey, David M. Brown, et al.. (2017). Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 1(6). 474–485. 65 indexed citations
6.
7.
Cameron, Alison, Julia Chisholm, Markus C. Elze, et al.. (2017). Role of radiotherapy to primary/metastatic sites in pediatric patients with metastatic rhabdomyosarcoma in the BERNIE study.. Journal of Clinical Oncology. 35(15_suppl). 10541–10541. 4 indexed citations
8.
Chisholm, Julia, Johannes H. M. Merks, Michela Casanova, et al.. (2016). BERNIE: Open-label, randomized, phase II study of bevacizumab plus chemotherapy in pediatric metastatic rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcoma (NRSTS).. Journal of Clinical Oncology. 34(15_suppl). 11054–11054. 2 indexed citations
9.
Stefan, Norbert, Paul Jordan, Bettina Nowotny, et al.. (2014). Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2(5). 406–416. 92 indexed citations
10.
Surh, Linda, Sabine Fürst‐Recktenwald, Achille Iolascon, et al.. (2011). Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases. The Journal of Clinical Pharmacology. 52(5). 704–716. 13 indexed citations
11.
Horvath, Karl, Gerlies Bock, Werner Regittnig, et al.. (2007). Insulin glulisine, insulin lispro and regular human insulin show comparable end‐organ metabolic effects: an exploratory study. Diabetes Obesity and Metabolism. 10(6). 484–491. 10 indexed citations
12.
Fürst‐Recktenwald, Sabine, Helmuth G. Dörr, & Frank Rosanowski. (2000). Androglottia in a Young Female Adolescent with Congenital Adrenal Hyperplasia and 21-Hydroxylase Deficiency. Journal of Pediatric Endocrinology and Metabolism. 13(7). 959–62. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zijian Tian Breakdown of academic impact, for papers by Halil Gürhan Karabulut Breakdown of academic impact, for papers by Pernille M. Hansen Breakdown of academic impact, for papers by Saba Kiremitçi Breakdown of academic impact, for papers by Sevilay Sezer Breakdown of academic impact, for papers by Nicholas Fung Breakdown of academic impact, for papers by Dandan Zhu Breakdown of academic impact, for papers by Lárus Jónasson Breakdown of academic impact, for papers by Takahisa Kobayashi Breakdown of academic impact, for papers by Meredith Kato
Rankless by CCL
2026